A double-bind randomized comparison of the efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in acutely agitated patients with schizophrenia
Phase of Trial: Phase III
Latest Information Update: 16 Apr 2014
At a glance
- Drugs Olanzapine (Primary) ; Haloperidol
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 16 Apr 2014 Results published in the Journal of Clinical Psychopharmacology.
- 20 Jun 2007 New trial record.